End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
185,900 KRW | -3.33% | +6.53% | +88.73% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+88.73% | 7.46B | |
-1.62% | 89.22B | |
+1.32% | 40.49B | |
-15.84% | 32.79B | |
+64.13% | 26.23B | |
-21.34% | 14.52B | |
-7.95% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- A196170 Stock
- News ALTEOGEN Inc.
- ALTEOGEN Inc. announced that it has received KRW 74.999925 billion in funding from SG Core Co., Ltd.